(MedPage Today) — CHICAGO — An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with obesity with or without type 2 diabetes, a phase II randomized trial showed.
In the obesity…
Source link : https://www.medpagetoday.com/meetingcoverage/ada/116194
Author :
Publish date : 2025-06-23 18:30:00
Copyright for syndicated content belongs to the linked Source.
